Latest Update (as of September 3, 2026): Two major developments have moved this case since publication. On June 25, 2026, the U.S. Supreme Court ruled 7-2 in Monsanto Co. v. Durnell that federal law (FIFRA) preempts state failure-to-warn claims when the EPA has not required a cancer warning on a pesticide label — a significant win for Bayer that limits future state-court claims over Roundup’s warning label. Separately, Bayer’s proposed $7.25 billion nationwide class settlement, meant to resolve current and future claims over 21 years, is still awaiting final court approval. After two prior delays, the fairness hearing is now scheduled for September 14, 2026, giving the court and claims administrator more time to process opt-out disputes tied to the Supreme Court ruling.
Last updated: September 2026
The Roundup cancer lawsuit is one of the largest product liability cases in American history, and as of 2026, people can still file claims.
Bayer, the company that acquired Monsanto in 2018, has already paid out billions in settlements. But active litigation continues. New claimants are still being accepted.
This article covers what the lawsuit is about, who qualifies, what the payouts look like, and exactly how to file a claim in 2026. Whether you used Roundup for years on your farm, your lawn, or your job site, what you read here matters to you directly.
One fact that surprises most people: over 160,000 cases have been filed as of early 2026. That number tells you this is not a small or speculative lawsuit.
What Is the Roundup Cancer Lawsuit?
The Roundup cancer lawsuit is a product liability case against Monsanto, later acquired by Bayer AG, alleging that their weed killer Roundup causes cancer, specifically non-Hodgkin’s lymphoma.
Plaintiffs argue that Monsanto knew about the cancer risk for decades and failed to warn consumers. Three landmark jury verdicts between 2018 and 2019 proved that argument could win in court.
In 2018, a California jury awarded Dewayne Johnson, a school groundskeeper, $289 million (later reduced to $78.5 million). That verdict cracked open the floodgates.
| Case Name | Year | Original Award | Final Award |
|---|---|---|---|
| Johnson v. Monsanto | 2018 | $289 million | $78.5 million |
| Hardeman v. Monsanto | 2019 | $80 million | $25 million |
| Pilliod v. Monsanto | 2019 | $2.055 billion | $86.7 million |
These cases confirmed that juries believe glyphosate causes cancer. That confirmation changed everything for future claimants.
Roundup Lawsuit Update 2026
As of 2026, the Roundup lawsuit remains active, with new cases being filed and appeals still working through the courts.
Bayer set aside $10.9 billion in 2020 to resolve Roundup claims. But that fund did not close the door. Tens of thousands of claims remained unresolved entering 2026.
The U.S. Supreme Court declined to hear Bayer’s challenge in 2022, leaving state court liability in place. That ruling kept the litigation alive in states across the country.
Key 2026 developments:
- New claimants diagnosed after 2020 are still eligible to file
- State courts continue to accept personal injury cases
- Bayer has not reached a global resolution despite ongoing settlement talks
- Scientific evidence linking glyphosate to cancer has grown stronger, not weaker
Bayer’s own financial disclosures in early 2026 flagged ongoing Roundup litigation as a material financial risk. That tells you the company itself does not consider this fight over.
Key Takeaway: The Roundup cancer lawsuit is not finished. New claims are being accepted in 2026, and Bayer still faces billions in potential liability.
Does Roundup Cause Cancer? What the Science Says
Roundup causes cancer, according to the International Agency for Research on Cancer (IARC), which classified glyphosate as a Group 2A probable human carcinogen in 2015.
That classification was a turning point. Thousands of studies have followed. The strongest evidence points to non-Hodgkin’s lymphoma as the primary cancer associated with glyphosate exposure.
A 2019 meta-analysis published in Mutation Research found that people exposed to glyphosate-based herbicides faced a 41% higher risk of developing non-Hodgkin’s lymphoma compared to those with no exposure.
| Scientific Body | Finding | Year |
|---|---|---|
| IARC (WHO) | Group 2A: Probable human carcinogen | 2015 |
| Mutation Research | 41% increased NHL risk | 2019 |
| EPA | Unlikely to be carcinogenic to humans | 2020 |
| Multiple peer-reviewed journals | Consistent lymphoma association | 2016 to present |
The EPA’s contradictory assessment is one reason this lawsuit is complicated. But courts have repeatedly sided with plaintiffs, not the EPA’s conclusion.
Roundup Glyphosate Cancer Lawsuit: The Chemical at the Center
Glyphosate is the active herbicide in Roundup and the chemical at the center of every Roundup cancer lawsuit claim.
Monsanto patented glyphosate in 1974. Roundup became the most widely used herbicide on Earth. By 2016, over 1.8 billion pounds of glyphosate were applied annually worldwide.
The problem is not just glyphosate alone. Researchers have found that Roundup’s formulation, including surfactants and other ingredients mixed with glyphosate, may be even more toxic to human cells than pure glyphosate by itself.
Glyphosate exposure sources in the lawsuit:
- Professional lawn care and landscaping work
- Farming and agricultural use
- Golf course maintenance
- School and park groundskeeping
- Home garden and lawn treatment
If you used Roundup repeatedly, in any of those settings, your exposure history is relevant to your eligibility.
Roundup Non-Hodgkin’s Lymphoma Lawsuit: The Primary Cancer Linked
Non-Hodgkin’s lymphoma (NHL) is the cancer most directly tied to Roundup use, and it forms the basis of most active Roundup non-Hodgkin’s lymphoma lawsuit claims.
NHL is a group of blood cancers that affect the lymphatic system. It includes several subtypes, and multiple studies have found glyphosate exposure increases the risk of several of them.
The subtypes seen most often in Roundup lawsuits include:
- Diffuse large B-cell lymphoma (DLBCL)
- Follicular lymphoma
- Mantle cell lymphoma
- T-cell lymphoma
- Marginal zone lymphoma
Lawyers filing these cases have had the most consistent success when the plaintiff has a confirmed NHL diagnosis and a documented history of Roundup exposure. Other cancers have been named in some cases, but NHL remains the strongest foundation.
Key Takeaway: Non-Hodgkin’s lymphoma is the primary qualifying cancer for Roundup claims, and multiple subtypes are recognized.
Bayer Roundup Cancer Lawsuit: How Bayer Became the Defendant
Bayer AG became the face of the Roundup cancer lawsuit when it acquired Monsanto for $63 billion in 2018, inheriting every pending lawsuit along with it.
That acquisition turned into one of the most financially painful corporate decisions in recent memory. Within months, Bayer’s stock dropped by more than 40% as the scale of Roundup litigation became clear.
Bayer has maintained publicly that glyphosate is safe. At the same time, the company has paid out billions to make claims go away. That contradiction has not been lost on courts or the public.
| Bayer Action | Detail |
|---|---|
| Monsanto acquisition | $63 billion, closed June 2018 |
| Settlement fund announced | $10.9 billion, 2020 |
| Stock price decline post-acquisition | More than 40% drop |
| Ongoing litigation as of 2026 | Tens of thousands of active claims |
Bayer tried to create a “Roundup Future Claims” settlement structure to limit future liability. The U.S. Supreme Court declined to approve it in its proposed form, leaving Bayer exposed to ongoing claims.
Monsanto Roundup Lawsuit: The Company That Started It All
The Monsanto Roundup lawsuit predates Bayer’s involvement. Monsanto is the company that created Roundup, marketed it aggressively, and allegedly suppressed internal research that showed cancer risks.
Internal emails and documents surfaced during discovery in multiple trials showing that Monsanto had communications with EPA officials, attempted to influence scientific publications, and was aware that some researchers were raising red flags about glyphosate.
One key document set, called the “Monsanto Papers,” showed the company ghost-wrote scientific studies that were then published under independent researchers’ names.
Timeline of Monsanto’s key actions:
- 1974: Glyphosate patented; Roundup launched
- 1996: FDA settlement over misleading “biodegradable” claims
- 2015: IARC classifies glyphosate as Group 2A carcinogen
- 2018: Monsanto acquired by Bayer; first trial loss (Johnson case)
- 2019: Two more major jury losses (Hardeman, Pilliod)
Those internal documents remain powerful evidence in active 2026 cases.
Key Takeaway: Monsanto’s own internal documents showing awareness of cancer risks are central evidence in every active Roundup lawsuit in 2026.
Roundup Lawsuit Who Qualifies
You may qualify for the Roundup lawsuit if you used Roundup regularly and were later diagnosed with certain cancers, particularly non-Hodgkin’s lymphoma.
The general eligibility framework used by mass tort attorneys in 2026 looks at four core criteria. You need most or all of these to have a strong claim.
| Eligibility Factor | What It Means |
|---|---|
| Product use | You used Roundup or another glyphosate-based herbicide |
| Exposure duration | Regular use over months or years, not a single application |
| Cancer diagnosis | Non-Hodgkin’s lymphoma or related blood cancer diagnosed |
| Timing | Diagnosis must follow a period of exposure |
People who used Roundup just once or twice and have no cancer diagnosis do not have a current case. The lawsuits are personal injury claims, meaning you need an actual diagnosed injury.
Family members of someone who died from NHL after Roundup use can file a wrongful death claim. Those claims remain open in 2026.
Roundup Lawsuit Eligibility Requirements
The full Roundup lawsuit eligibility requirements in 2026 go beyond just having used the product and getting sick. Attorneys look at a specific set of qualifying conditions.
Think of it like a checklist. The more boxes you check, the stronger your claim. Missing one does not automatically disqualify you, but it changes the value and viability of the case.
Full eligibility checklist for 2026:
- Used Roundup weed killer or a glyphosate-based product
- Used it regularly for at least two or more years (professional exposure for even shorter periods may qualify)
- Diagnosed with non-Hodgkin’s lymphoma or a closely related blood cancer
- Cancer diagnosis came after the period of Roundup use began
- Can document exposure through employment records, purchase receipts, medical records, or witness testimony
- Diagnosis occurred within the statute of limitations window (varies by state)
People who qualify but did not file before earlier settlement deadlines may still have options in 2026 through individual litigation rather than the settlement fund.
Roundup Lawsuit Settlement Amount
The Roundup lawsuit settlement amounts vary widely, but the overall settlement fund Bayer established was $10.9 billion across approximately 100,000 resolved claims.
That works out to a rough average of around $100,000 per resolved case before attorney fees and costs. But averages are misleading here. Individual settlements range from tens of thousands of dollars to well over a million.
| Claim Category | Estimated Settlement Range |
|---|---|
| Mild diagnosis, limited exposure | $20,000 to $80,000 |
| Moderate diagnosis, confirmed long-term use | $80,000 to $250,000 |
| Severe cancer, strong exposure history | $250,000 to $500,000 |
| Death/wrongful death with strong evidence | $500,000 to $2 million+ |
| Trial verdict (exceptional cases) | $10 million to $2 billion |
These ranges reflect patterns from resolved cases. Your specific outcome depends on your medical records, exposure history, age, financial losses, and the quality of your legal representation.
Key Takeaway: Roundup settlement amounts range from $20,000 to over $2 million depending on cancer severity, exposure duration, and strength of evidence.
Roundup Lawsuit Payout Per Person
The Roundup lawsuit payout per person depends on several factors, but most individuals who settled through the 2020 Bayer fund received between $5,000 and $250,000.
That range is broader than most websites admit. It reflects the reality that mass tort settlements do not pay everyone the same amount. The process involves a scoring system that assigns point values to different aspects of your case.
Factors that increase your individual payout:
- A more serious or aggressive cancer diagnosis
- Younger age at diagnosis
- Longer documented history of Roundup exposure
- Higher income loss due to illness
- Surviving as a claimant versus a wrongful death case
- Strong medical expert support linking exposure to diagnosis
Factors that decrease your payout:
- Short or undocumented exposure history
- Other potential causes of cancer in your background
- Older age at diagnosis
- Prior settlements or unrelated medical conditions
Claimants going through individual litigation in 2026, outside the settlement fund, may receive higher payouts if they take their case to trial and win.
What Is the Roundup Lawsuit Average Settlement?
The Roundup lawsuit average settlement across all resolved claims through Bayer’s fund is estimated at approximately $160,000 per plaintiff, according to legal industry reports tracking mass tort resolutions.
That figure comes from dividing the total settlement fund against the number of resolved cases. The actual median settlement, meaning the middle number in the range, is lower, closer to $70,000 to $100,000.
Here is why that distinction matters. A small number of very large trial verdicts pull the average up. Most individual claimants receive a figure closer to the median, not the average.
| Settlement Metric | Estimated Figure |
|---|---|
| Total Bayer settlement fund | $10.9 billion |
| Approximate claims resolved | 100,000 |
| Average per claim | ~$109,000 |
| Median settlement estimate | $70,000 to $100,000 |
| High-end trial verdicts | $10 million to $2 billion |
For 2026 claimants filing new cases, the likely outcome is a negotiated settlement rather than a trial. Most mass torts resolve through settlement, not jury verdicts.
Roundup Weed Killer Cancer Lawsuit: Who Has Used This Product?
The Roundup weed killer cancer lawsuit covers anyone who used Roundup or any other glyphosate-based herbicide and later developed a qualifying cancer diagnosis.
Roundup is not just one product. Monsanto and later Bayer sold it under dozens of product names and formulations. If the label said “glyphosate” or the active ingredient was glyphosate, it counts.
People commonly included in these lawsuits:
- Farmers who applied glyphosate herbicides to crops for years
- Home gardeners and lawn care consumers
- Golf course and landscape maintenance workers
- Municipal parks and public grounds employees
- School and university groundskeepers
- Agricultural employees on farms and nurseries
One important point: you do not need to have worked professionally with Roundup. Home users who applied it regularly in their backyard for many years have successfully filed claims.
Key Takeaway: Any person who regularly used Roundup or a glyphosate herbicide and was diagnosed with NHL may qualify, including home gardeners and landscapers.
Is Roundup Still Being Sued in 2026?
Yes, Roundup is still being actively sued in 2026, making it one of the longest-running active mass tort cases in American legal history.
Despite Bayer’s multi-billion dollar settlement fund, the company did not achieve a global resolution. State courts continue to accept new filings. Appeals courts are still deciding key legal questions.
Current 2026 litigation status:
- Active individual lawsuits in state courts across the U.S.
- New diagnoses continue to generate new eligible claimants
- Bayer’s push for Supreme Court protection against state-law claims failed
- Attorneys continue enrolling new clients diagnosed with NHL
The most common comparison in legal circles is asbestos litigation, which has continued for over 40 years. Roundup litigation, while not identical, shares the same long-tail structure. New cases will likely continue past 2030.
Roundup Lawsuit Filing Deadline 2026
The Roundup lawsuit filing deadline in 2026 varies by state because personal injury statutes of limitations differ across the country.
There is no single national deadline for Roundup claims. Each state sets its own window, typically starting from the date of cancer diagnosis or the date a person reasonably could have known their cancer was linked to Roundup.
| State | Statute of Limitations | Notes |
|---|---|---|
| California | 2 years from diagnosis | Discovery rule applies |
| Texas | 2 years from diagnosis | Strict enforcement |
| Florida | 2 years (changed from 4) | 2023 law change affects some cases |
| New York | 3 years | Discovery rule may extend it |
| Illinois | 2 years | Some exceptions available |
Key point: If you were diagnosed more than two years ago and have not yet filed, you may still have time under the discovery rule, which starts the clock from when you knew or should have known the link to Roundup.
Do not assume the deadline has passed without checking your state’s specific rules.
Roundup Lawsuit Statute of Limitations
The Roundup lawsuit statute of limitations is the legal time limit you have to file your claim, and missing it means losing your right to sue permanently.
Most states give you two to three years from the date of diagnosis to file a personal injury lawsuit. In wrongful death cases, the clock typically starts from the date of death.
How the discovery rule helps:
The discovery rule says the statute of limitations starts not on the date of diagnosis, but on the date you first discovered, or reasonably should have discovered, that Roundup caused your cancer.
This matters because many people were diagnosed with NHL years ago and did not know until recently that Roundup may have caused it. In those cases, the statute may not have started running yet.
| Situation | When Clock Starts |
|---|---|
| Standard personal injury | Date of cancer diagnosis |
| Discovery rule applies | Date you learned of Roundup cancer link |
| Wrongful death | Date of death from NHL |
| Minors | Often tolled until age of majority |
Getting a legal review of your timeline is the only way to know for certain whether your deadline has passed.
How to File a Roundup Lawsuit in 2026
Filing a Roundup lawsuit in 2026 starts with contacting a mass tort attorney who handles Roundup cases and providing them with your medical and exposure history.
You do not file directly with a court on your own in most cases. Mass tort law firms gather your information, evaluate your claim, and handle all the legal work on a contingency fee basis. That means you pay nothing upfront.
Step-by-step filing process:
- Contact a mass tort law firm handling Roundup cases
- Provide your cancer diagnosis records (pathology report, oncologist notes)
- Document your Roundup exposure (employment records, purchase receipts, photos, witness statements)
- The attorney evaluates your claim at no cost to you
- If accepted, you sign a retainer agreement (contingency fee, typically 33% to 40% of recovery)
- Your attorney files your case in the appropriate court
- The case proceeds through discovery, potential mediation, and settlement or trial
Most Roundup cases resolve before trial. The process from filing to settlement has ranged from 12 to 36 months depending on the complexity of the case and court backlog.
Key Takeaway: Filing a Roundup lawsuit in 2026 starts with a free case evaluation. Attorneys work on contingency, so you owe nothing unless you win.
Roundup Lawsuit Cancer: The Diagnoses That Drive These Cases
The Roundup lawsuit cancer connection is primarily about non-Hodgkin’s lymphoma, but courts have also heard cases involving other glyphosate-linked blood cancers.
NHL is the anchor diagnosis for this litigation. But within the NHL category, there are multiple specific diagnoses that plaintiffs have brought successfully to court and to settlement negotiations.
Qualifying cancer diagnoses in 2026:
- Diffuse large B-cell lymphoma (most common in filed cases)
- Follicular lymphoma
- Mantle cell lymphoma
- Marginal zone lymphoma
- Small lymphocytic lymphoma
- T-cell lymphomas (various subtypes)
- Burkitt lymphoma
Some law firms have also accepted cases involving hairy cell leukemia and multiple myeloma, though these have a smaller body of supporting research than NHL.
| Cancer Type | Strength of Evidence | Common in Roundup Cases |
|---|---|---|
| Diffuse large B-cell lymphoma | Very strong | Yes |
| Follicular lymphoma | Strong | Yes |
| Mantle cell lymphoma | Moderate to strong | Yes |
| Hairy cell leukemia | Moderate | Sometimes |
| Multiple myeloma | Moderate | Sometimes |
If your diagnosis is not on this list, a case evaluation from a mass tort attorney is still worth pursuing. The science on glyphosate continues to expand.
Frequently Asked Questions
What cancers qualify for the Roundup cancer lawsuit?
Non-Hodgkin’s lymphoma is the primary cancer that qualifies for the Roundup cancer lawsuit.
Multiple subtypes qualify, including diffuse large B-cell lymphoma, follicular lymphoma, and mantle cell lymphoma.
Some law firms also accept hairy cell leukemia and multiple myeloma cases with documented glyphosate exposure.
How much money can you get from a Roundup lawsuit settlement?
Most Roundup lawsuit settlements range from $20,000 to $500,000 depending on the severity of your diagnosis and exposure history.
Exceptional trial cases have resulted in verdicts in the tens of millions, but those are rare.
The median settlement for resolved claims is estimated between $70,000 and $100,000 before attorney fees.
Is it too late to file a Roundup cancer lawsuit in 2026?
It is not too late for many people to file a Roundup cancer lawsuit in 2026.
New cases are actively being accepted, and the discovery rule in most states may extend your deadline beyond your initial diagnosis date.
The safest step is a free case evaluation with a mass tort attorney to confirm your specific filing window.
How do you prove Roundup caused your cancer?
Proving Roundup caused your cancer requires documenting your exposure history and connecting it to your diagnosis through medical expert testimony.
Attorneys use employment records, purchase receipts, medical records, and expert oncologists who can testify about the glyphosate-NHL link.
Courts have accepted this type of evidence in every major Roundup trial since 2018.
What is the average Roundup lawsuit payout per person?
The average Roundup lawsuit payout per person is approximately $109,000 based on the total settlement fund divided across resolved claims.
However, the median individual settlement is closer to $70,000 to $100,000, with higher amounts going to more severe cases.
Your actual payout depends on your specific diagnosis, documented exposure, lost income, and other damages.
Where Things Stand and What You Should Do
The Roundup cancer lawsuit is still one of the most active mass tort cases in the country. Thousands of people are still being diagnosed with NHL every year, and many of them used Roundup for years without knowing the risk.
If you used Roundup regularly and received a cancer diagnosis, the question is not whether the lawsuit is real. Three jury verdicts, $10.9 billion in settlements, and over 160,000 filed cases have already answered that. The question is whether your specific situation qualifies.
Get a case evaluation done. It costs nothing. It takes less time than you think. And for people with legitimate claims, the compensation can cover medical bills, lost income, and the real financial damage that cancer causes to a family’s life.
